Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003
Published online before print September 11, 2003, doi: 10.1161/01.RES.0000095245.97945.FE
A more recent version of this article appeared on October 3, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/7/656    most recent
01.RES.0000095245.97945.FEv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cogolludo, A.
Right arrow Articles by Perez-Vizcaino, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cogolludo, A.
Right arrow Articles by Perez-Vizcaino, F.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Ion channels/membrane transport
Right arrow Pulmonary biology and circulation
Right arrow Pulmonary circulation and disease

Submitted on May 13, 2003
Revised on September 2, 2003
Accepted on September 3, 2003

Thromboxane A2-Induced Inhibition of Voltage-Gated K+ Channels and Pulmonary Vasoconstriction. Role of Protein Kinase C{zeta}

Angel Cogolludo *; Laura Moreno ; Lisardo Bosca ; Juan Tamargo ; and Francisco Perez-Vizcaino

From the Institutes of Pharmacology and Toxicology and Biochemistry (L.B.), School of Medicine, Universidad Complutense, Madrid, Spain.

* To whom correspondence should be addressed. E-mail: acogolludo{at}ift.csic.es.

Voltage-gated K+ channels (KV) and thromboxane A2 (TXA2) play critical roles in controlling pulmonary arterial tone under physiological and pathological conditions. We hypothesized that TXA2 might inhibit KV channels, thereby establishing a link between these two major pathogenic pathways in pulmonary hypertension. The TXA2 analogue U46619 inhibited IK(V) (Emax=56.1±3.9%, EC50=0.054±0.019 µmol/L) and depolarized pulmonary artery smooth muscle cells via activation of TP receptors. In isolated pulmonary arteries, U46619 simultaneously increased intracellular Ca2+ concentration and contractile force, and these effects were inhibited by nifedipine or KCl (60 mmol/L). U46619-induced contractions were not altered by the inhibitors of tyrosine kinase genistein or Rho kinase Y-27632 but were prevented by the nonselective protein kinase C (PKC) inhibitors staurosporine and calphostin C. Furthermore, these responses were sensitive to Gö-6983 but insensitive to bisindolylmaleimide I and Gö-6976. Based on the specificity of these drugs, we suggested a role for an atypical PKC in U46619-induced effects. Thus, treatment with a PKC{zeta} pseudosubstrate inhibitor markedly prevented the vasoconstriction, the inhibition of IK(V), and the depolarization induced by U46619. Western blots showed a transient translocation of PKC{zeta} from the cytosolic to the particulate fraction on stimulation with U46619. These results indicate that TXA2 inhibits IK(V), leading to depolarization, activation of L-type Ca2+ channels, and vasoconstriction of rat pulmonary arteries. We propose PKC{zeta} as a link between TP receptor activation and KV channel inhibition.


Key words: K+ channels • pulmonary artery • protein kinase C • thromboxane A2




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Xu, O. Platoshyn, A. Makino, W. H. Dillmann, K. Akassoglou, C. V. Remillard, and J. X.-J. Yuan
Characterization of agonist-induced vasoconstriction in mouse pulmonary artery
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H220 - H228.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Moreno, G. Frazziano, A. Cogolludo, L. Cobeno, J. Tamargo, and F. Perez-Vizcaino
Role of Protein Kinase C{zeta} and Its Adaptor Protein p62 in Voltage-Gated Potassium Channel Modulation in Pulmonary Arteries
Mol. Pharmacol., November 1, 2007; 72(5): 1301 - 1309.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. J. Sampson, L. M. Davies, R. Barrett-Jolley, N. B. Standen, and C. Dart
Angiotensin II-activated protein kinase C targets caveolae to inhibit aortic ATP-sensitive potassium channels
Cardiovasc Res, October 1, 2007; 76(1): 61 - 70.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Cogolludo, G. Frazziano, A. M. Briones, L. Cobeno, L. Moreno, F. Lodi, M. Salaices, J. Tamargo, and F. Perez-Vizcaino
The dietary flavonoid quercetin activates BKCa currents in coronary arteries via production of H2O2. Role in vasodilatation
Cardiovasc Res, January 15, 2007; 73(2): 424 - 431.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J. Blanco-Rivero, A. Sagredo, G. Balfagon, and M. Ferrer
Protein kinase C activation increases endothelial nitric oxide release in mesenteric arteries from orchidectomized rats
J. Endocrinol., January 1, 2007; 192(1): 189 - 197.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Wareing, S. L. Greenwood, G. K. Fyfe, and P. N. Baker
Reactivity of Human Placental Chorionic Plate Vessels from Pregnancies Complicated by Intrauterine Growth Restriction (IUGR)
Biol Reprod, October 1, 2006; 75(4): 518 - 523.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Budzyn, M. Paull, P. D. Marley, and C. G. Sobey
Segmental Differences in the Roles of Rho-Kinase and Protein Kinase C in Mediating Vasoconstriction
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 791 - 796.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Cogolludo, L. Moreno, F. Lodi, G. Frazziano, L. Cobeno, J. Tamargo, and F. Perez-Vizcaino
Serotonin Inhibits Voltage-Gated K+ Currents in Pulmonary Artery Smooth Muscle Cells: Role of 5-HT2A Receptors, Caveolin-1, and KV1.5 Channel Internalization
Circ. Res., April 14, 2006; 98(7): 931 - 938.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
V. A. Snetkov, G. A Knock, L. Baxter, G. D. Thomas, J. P. T. Ward, and P. I. Aaronson
Mechanisms of the prostaglandin F2{alpha}-induced rise in [Ca2+]i in rat intrapulmonary arteries
J. Physiol., February 15, 2006; 571(1): 147 - 163.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Hinton, L. Mellow, A. J. Halayko, A. Gutsol, and S. Dakshinamurti
Hypoxia induces hypersensitivity and hyperreactivity to thromboxane receptor agonist in neonatal pulmonary arterial myocytes
Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L375 - L384.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. Ding and P. A. Murray
Cellular mechanisms of thromboxane A2-mediated contraction in pulmonary veins
Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L825 - L833.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Song, J. E. Jones, H. Beppu, J. F. Keaney Jr, J. Loscalzo, and Y.-Y. Zhang
Increased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice
Circulation, July 26, 2005; 112(4): 553 - 562.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Cogolludo, L. Moreno, F. Lodi, J. Tamargo, and F. Perez-Vizcaino
Postnatal maturational shift from PKC{zeta} and voltage-gated K+ channels to RhoA/Rho kinase in pulmonary vasoconstriction
Cardiovasc Res, April 1, 2005; 66(1): 84 - 93.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. T. Kurjiaka, S. B. Bender, D. D. Nye, W. B. Wiehler, and D. G. Welsh
Hypertension attenuates cell-to-cell communication in hamster retractor muscle feed arteries
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H861 - H870.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. W. Hopf, W. S. Mailliard, G. F. Gonzalez, I. Diamond, and A. Bonci
Atypical Protein Kinase C Is a Novel Mediator of Dopamine-Enhanced Firing in Nucleus Accumbens Neurons
J. Neurosci., January 26, 2005; 25(4): 985 - 989.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. Moreno, G. Gonzalez-Luis, A. Cogolludo, F. Lodi, A. Lopez-Farre, J. Tamargo, E. Villamor, and F. Perez-Vizcaino
Soluble guanylyl cyclase during postnatal porcine pulmonary maturation
Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L125 - L130.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. Ding and P. A. Murray
Regulation of pulmonary venous tone in response to muscarinic receptor activation
Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L131 - L140.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Luykenaar, S. E. Brett, B. N. Wu, W. B. Wiehler, and D. G. Welsh
Pyrimidine nucleotides suppress KDR currents and depolarize rat cerebral arteries by activating Rho kinase
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1088 - H1100.
[Abstract] [Full Text] [PDF]